NCT05465200 Lower Silesia Cardiogenic Shock Initiative
| NCT ID | NCT05465200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wroclaw Medical University |
| Condition | Cardiogenic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2022-01-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
LSCSI is a Hub\&Spoke project with the main aim to improve the outcome of patients with cardiogenic shock in Lower Silesia region, Poland. It consists of one "hub" which is Wroclaw University Hospital and eleven "spokes" which are eleven cardiology departments situated in Lower Silesian Voivodeship. The consortium have unified protocol defining which cardiogenic shock patient and when should be transferred to the "hub" for enhanced treatment options including durable mechanical circulatory support or heart transplant. The "hub" have 7/24 Shock Team on-site supplied with a protocol how to proceed with "spoke" transferred patients including decision making on which mechanical circulatory support implant with subsequent de-escalation or escalation pathway.
Eligibility Criteria
Inclusion Criteria: 1. Fulfilled definition of cardiogenic shock 2. Age 18 - 60 years 3. Shock duration below 24 hours Exclusion Criteria: 1. History of cardiac arrest with anoxemic brain injury 2. Irreversible multiorgan failure 3. End stage of chronic diseases other than heart failure 4. Neoplastic disease 5. Lack of vascular access
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05465200 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Cardiogenic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05465200 currently recruiting?
Yes, NCT05465200 is actively recruiting participants. Contact the research team at wiktor.kuliczkowski@umed.wroc.pl for enrollment information.
Where is the NCT05465200 trial being conducted?
This trial is being conducted at Wroclaw, Poland.
Who is sponsoring the NCT05465200 clinical trial?
NCT05465200 is sponsored by Wroclaw Medical University. The trial plans to enroll 50 participants.